Skip to content

Drug interactions

Lenacapavir + Paclitaxel

Severity: Moderate

Lenacapavir and Paclitaxel: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenacapavir is a moderate CYP3A inhibitor with a long half-life, so effects may persist for months after the last dose. Paclitaxel exposure may increase modestly through its CYP3A4 pathway.

What this interaction means in plain words

Lenacapavir and Paclitaxel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lenacapavir belongs to Anti Virals; Paclitaxel belongs to Oncology.

Evidence level: Low

Why it happens

Lenacapavir inhibits CYP3A4, reducing the secondary metabolism of paclitaxel.

What to do

Monitor blood counts and neuropathy during paclitaxel therapy, including in patients who recently received lenacapavir injections.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lenacapavir and Paclitaxel, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lenacapavir with Paclitaxel?

MediHelp rates the interaction as moderate. Lenacapavir and Paclitaxel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lenacapavir is a moderate CYP3A inhibitor with a long half-life, so effects may persist for months after the last dose. Paclitaxel exposure may increase modestly through its CYP3A4 pathway.

How serious is the interaction between Lenacapavir and Paclitaxel?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and neuropathy during paclitaxel therapy, including in patients who recently received lenacapavir injections.

What other medicines interact with Paclitaxel?

MediHelp also lists interactions of Paclitaxel with, for example, Adenovirus types 4 and 7 live, Cobicistat, Cyclosporine. The full list is on the Paclitaxel page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in